Two new isoflavanones, eryvarins Y (1) and Z (2), together with three known compounds (3-5) were isolated from the roots of Erythrina variegata. The structures of 1 and 2 were established on the basis of spectroscopic data. The new compounds are peculiar isoflavanones, possessing both a 3-methylbut-2-en-1-yl group and a 2-hydroxy-3-methylbut-3-en-1-yl group. Among the isolates, orientanol E (5) exhibited potent antibacterial activity against methicillinresistant Staphylococcus aureus (MRSA) strains. Erythrina variegata L. (Leguminosae) is distributed in the tropical and subtropical coastal regions of the Pacific and Indian Oceans. This plant is medicinally used as an antibacterial, antiinflammatory, antipyretic, and antiseptic agent in China [1]. Previous chemical investigations of this plant afforded a number of phenolic secondary metabolites, such as arylbenzofurans, chromen-4-one derivatives, isoflavanones, isoflavones, isoflavenes, and pterocarpans [2-9], of which some isoflavonoids (bidwillon B [10], erycristagallin [11], orientanol B [11], and eryvarins Q [6], U [7] and W [8]) possess a potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Eryvarin Y (1) was obtained as an amorphous powder and assigned the molecular formula of C 25 H 28 O 6 ([M] + m/z 424.1878) from the HREIMS. This compound was determined to be an isoflavanone derivative based on the characteristic spectral data [1653 cm -1 for conjugated carbonyl function in the IR spectrum and a set of aliphatic proton signals:  4.65 (dd, J = 12.1, 4.5 Hz, H-2a), 4.86 (dd, J = 12.1, 4.5 Hz, H-2b), and 3.88 (t-like, J = 4.5 Hz, H-3) in the 1 H NMR spectrum] [6] ( Table 1 ). The 1 H NMR spectrum revealed an aromatic proton signal  7.61 (1H, s) on the A-ring and three aromatic proton signals [ 6.31 (1H, dd, J = 8.3, 2.3 Hz), 6.36 (1H, d, J = 2.3 Hz), 7.20 (1H, d, J = 8.3)] on a 2,4-dihydroxyphenyl moiety, as well as a 3-methylbut-2-en-1-yl group (1.68, 1.72, 3.25, and 5.26) and a 2-hydroxy-3-methylbut-3-en-1-yl moiety (1.86, 2.85, 3.12, 4.35, 4.89, and 4.98) . The location of the aromatic proton at the C-5 position ( 7.61) was based on the HMBC spectrum, which showed correlations from H-5 to C-4, C-7, and C-9, as shown in Figure 2 . The assignment of the aromatic proton at the C-6' position ( 7.20) on the 2,4-dihydroxyphenyl group was obtained from the HMBC experiment (correlations: H-3/C-6' and H-6'/C-3). The assignment of the 3-methylbut-2-en-1-yl group at the C-6 position was achieved from both the HMBC spectrum (H-5/C-1′′, H-1′′/C-5, H-1′′/C-6, and H-1′′/C-7) and the NOESY spectrum (NOE interaction: H-5/H-2′′). The 2-hydroxy-3methylbut-3-en-1-yl unit was confirmed by the typical mass fragment at m/z 353 [M-C 4 H 7 O] + [12] , which was connected to the C-8 position, based on the HMBC spectrum (correlations: H-1'"/C-7, H-1'"/C-8, H-1'"/C-9, and H-2'"/C-8). Compound 1 was considered to be a racemic isoflavanone at the C-3 position, showing no Cotton effects in the CD spectrum [13] and the absolute configuration at C-2"' was not confirmed due to the limited amount available. Consequently, the structure of eryvarin Y was characterized as 7,2',4'-trihydroxy-8-(2'"-hydroxy-3'"-methylbut-3'"en-1-yl)-6-(3"-methylbut-2"-en-1-yl)isoflavanone.
Eryvarin Z (2) was obtained as an amorphous powder and assigned the same molecular formula of C 25 H 28 O 6 ([M] + m/z 424.1902) from the HREIMS. Compound 2 also has the isoflavanone skeleton, indicated by the characteristic spectral features [1654 cm -1 for a conjugated carbonyl function in the IR spectrum and a set of aliphatic proton signals: [10] as that of compound 1, was determined at the C-6 position by the HMBC spectrum (correlations: H-5/C-1", H-1"/C-5, H-1"/C-6, and H-1"/C-7). Thus, compound 2 is the regioisomer of 1, possessing 3methylbut-2-en-1-yl and 2-hydroxy-3-methylbut-3-en-1-yl groups on the A-ring. Compound 2 was a racemic isoflavanone (no Cotton effects in the CD spectrum [13] ) with undecided absolute configuration at the C-2" position. Consequently, the structure of eryvarin Z was characterized as 7,2',4'-trihydroxy-6-(2"-hydroxy-3"-methylbut-3"-en-1-yl)-8-(3'"-methylbut-2'"-en-1yl)isoflavanone.
The unambiguous assignment of the 1 H and 13 C NMR spectroscopic signals for 1 and 2 was accomplished by analyses of the 1 H-1 H COSY, HMQC, HMBC, and NOESY spectra.
The known compounds were identified as 6-demethylvignafuran (3) [14] , 2,3-dihydroauriculatin (4) [15] , and orientanol E (5) [16] by comparison of the spectroscopic data with either those of authentic samples or the reported values.
The antibacterial activity of the isolates 1-5 against 13 MRSA strains was estimated by determining their MIC and MBC using a broth dilution method. MIC 50 and MIC 90 were defined as the minimum concentrations needed to inhibit bacterial growth of 7 and 12 MRSA strains, respectively. In the same way, MBC 50 and MBC 90 indicated the minimum concentrations needed to inhibit the recovery of bacterial cells of 7 and 12 MRSA strains, respectively. Vancomycin was used as the positive control. As shown in Table 2 , compound 5 exhibited the highest growth inhibitory activity on the tested MRSA strains (1.56-12.5 g/mL), followed by 4 (6.25-25 g/mL), 1 (12.5-25 g/mL), 2 (25-50g/mL), and 3 (25->50 g/mL) in that order. Although compound 5 is a known compound, its anti-MRSA activity has not been estimated. This compound showed the same MIC 50 and MIC 90 values as those of vancomycin. The MBC 50 and MBC 90 values of 5 were also comparable with those of the anti-MRSA antibiotics. While compound 4 showed moderate MIC values against MRSA, the MBC 50 and MBC 90 values were much higher than those of vancomycin. The results indicated that the compound acts on MRSA in a bacteriostatic manner. On the contrary, compound 1 killed all the MRSA strains at 25 g/mL. Compounds 2 and 3 did not show any potent anti-MRSA activity in the concentration range. a Minimum concentration needed to inhibit the growth or recovery of 7 MRSA strains. b Minimum concentration needed to inhibit the growth or recovery of 12 MRSA strains. C Positive control.
Experimental

General experimental procedures:
Optical rotations were measured using a JASCO P-2000 digital polarimeter. The circular dichroism (CD) spectra were determined by a JASCO J-725 spectropolarimeter. The UV and IR spectra were obtained using JASCO V-560 and JASCO FT/IR-4200 spectrophotometers, respectively. The 1 H NMR (500 MHz) and 13 C NMR (125 MHz) spectra were recorded by a JEOL ECA-500 instrument using TMS as the internal standard. EIMS and HREIMS were recorded with a JEOL JMS-700 mass spectrometer. CC was carried out on Merck silica gel (230-400 mesh; Darmstadt, Germany). TLC was performed using Merck precoated silica gel (60 F 254 ). UV light and iodine vapor were used for detection of the compounds. 
